查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1547058

PMS、月经保健品市场：全球产业分析、规模、占有率、成长、趋势、预测，2024-2031年

PMS & Menstrual Health Supplements Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 210 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于PMS、月经保健品市场的综合报告。本报告全面评估了主要市场动态，包括驱动因素、趋势、机会和挑战，并提供了有关市场结构的详细见解。

关键见解

  • PMS、月经保健品市场规模（2024年）：242亿美元
  • 预测市场价值（2031年）：356亿美元
  • 全球市场成长率（2024-2031年年复合成长率）：5.6%

PMS、月经保健品市场：调查范围

PMS、月经保健品目的是缓解与经前症候群（PMS）相关的症状和经期不适（如腹胀、情绪低落和疼痛）。这些补充剂通常含有维生素、矿物质、草药萃取物和其他天然成分，目的是改善月经健康和整体健康。该市场迎合不同年龄层和健康状况的女性，提供各种产品，包括营养补充剂、草药和功能性食品。市场成长的驱动力是人们对月经健康的认识不断提高、对天然成分和有机补充剂的需求不断增加以及对女性健康和保健的日益关注。

推动市场成长的因素：

全球PMS、月经保健品市场由几个关键因素推动，包括人们对PMS、月经健康管理解决方案的认识和接受度不断提高。经前症候群/月经失调的盛行率不断上升，加上消费者对天然和有机补充剂的偏好不断增加，推动市场扩张。补充剂配方的技术进步，例如开发针对性和个人化的补充剂，将进一步推动市场成长。此外，透过线上平台和零售管道提供PMS、月经保健补充剂日益扩大消费者的获取和便利。

市场限制因素：

儘管成长前景广阔，PMS、月经保健品市场仍面临监管障碍、产品功效和安全挑战。监管标准因地区而异，这可能会对市场进入和产品审批带来障碍。此外，缺乏支持某些补充剂有效性的标准化临床证据可能会影响消费者信心和市场成长。高产品成本和有限的偿付选项也对广泛采用构成了挑战，特别是在价格敏感的市场。

市场机会：

由于不断变化的消费者偏好、人口趋势和补充剂配方的创新，PMS、月经保健补充剂市场呈现出巨大的成长机会。人们对个人化健康和保健解决方案的日益关注，为开发满足特定PMS、月经健康需求的客製化补充剂创造了机会。电子商务平台和保健食品商店等通路的扩大扩大了市场覆盖范围和可及性。策略合作伙伴关係、研发投资以及创新补充剂配方的推出对于利用新机会和维持市场成长非常重要。

本报告解决的关键问题

  • 推动PMS、月经保健品市场全球成长的关键因素是什么？
  • 市面上流行哪些类型的补充品和配方？
  • 补充剂技术的进步如何改变PMS、月经保健品市场的竞争格局？
  • 谁是对PMS、月经健康补充剂市场做出贡献的主要公司？
  • 全球PMS、月经保健品市场的新趋势和未来前景如何？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围与定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 课题
    • 主要趋势
  • 肉品替代品市场：价值链
    • 主要公司名单
    • 主要经销商名单
  • 预测因子 - 相关性和影响
  • 新冠肺炎（COVID-19）影响评估
  • PESTLE分析
  • 波特五力分析

第3章 主要法规/标准

第4章 2019-2031年价格趋势分析

  • 影响价格的主要因素
  • 以来源的价格

第5章 全球PMS、月经保健品市场展望：实绩（2019-2023年）与预测（2024-2031年）

  • 市场规模分析与预测（十亿美元）
    • 过去的市场规模分析，2019-2023年
    • 目前市场规模预测（2023-2031年）
  • 全球PMS、月经保健品市场展望：产品类型
    • 2019-2023年历史市场规模（十亿美元）分析，依产品类型
    • 2024-2031年目前市场规模（十亿美元）预测，依产品类型
    • 市场吸引力分析：产品类型
  • 全球经前症候群/月经健康补充品市场展望：依消费者群体
    • 2019-2023年历史市场规模（十亿美元）分析，依消费者群体
    • 2024-2031年当前市场规模预测（十亿美元），依消费者群体
    • 市场吸引力分析：消费者群体
  • 全球PMS、月经保健品市场展望：配方
    • 2019-2023年历史市场规模（十亿美元）分析：依配方
    • 对2024-2031年当前市场规模（十亿美元）的预测：依配方
    • 市场吸引力分析：表述
  • 全球PMS、月经保健品市场展望：症状
    • 2019-2023年过去的市场规模（十亿美元）分析，依症状
    • 2024-2031年当前市场规模（十亿美元）预测，依症状
    • 市场吸引力分析：症状
  • 全球经前症候群/经期保健补充品市场展望：依销售管道
    • 2019-2023年历史市场规模（十亿美元）分析：依类别
    • 2024-2031年当前市场规模（十亿美元）预测：依类别
    • 市场吸引力分析：销售管道

第6章 全球经前症候群/经期保健补充品市场展望：地区

  • 2019-2023年历史市场规模分析（十亿美元）：依地区
  • 2024-2031年当前市场规模预测（十亿美元）：依地区
    • 北美
    • 欧洲
    • 东亚
    • 南亚/大洋洲
    • 拉丁美洲
    • 中东、非洲
  • 市场吸引力分析：地区

第7章 北美PMS、月经保健品市场展望：结果（2019-2023年）与预测（2024-2031年）

第8章 欧洲PMS、月经保健品市场展望：结果（2019-2023年）与预测（2024-2031年）

第9章 东亚 PMS、月经保健品市场展望：结果（2019-2023年）与预测（2024-2031年）

第10章 南亚/大洋洲 PMS、月经保健品市场展望：实绩（2019-2023年）与预测（2024-2031年）

第11章 拉丁美洲PMS、月经保健品市场展望：实绩（2019-2023年）与预测（2024-2031年）

第12章 中东和非洲PMS、月经保健品市场展望：实绩（2019-2023年）和预测（2024-2031年）

第13章 竞争态势

  • 2023年市占率分析
  • 市场结构
    • 竞争强度图：依市场
    • 竞争仪表板
    • 层次结构分析
    • 区域分布分析
  • 公司简介（详细资料 - 概述、财务状况、策略、近期发展）
    • Herbalife International of America, Inc.
    • Pharmavite LLC
    • Nature's Bounty
    • Amway
    • GNC Holdings Inc.
    • USANA Health Sciences, Inc.
    • MetP Pharma AG
    • RBk Neutraceuticals Pty. Ltd.
    • Archer Daniels Midland
    • Power Gummies
    • Looni
    • DM Pharma

第14章 附录

  • 调查方法
  • 调查的先决条件
  • 首字母缩写词和缩写词
简介目录
Product Code: PMRREP34721

Persistence Market Research has recently released a comprehensive report on the PMS & Menstrual Health Supplements Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • PMS & Menstrual Health Supplements Market Size (2024E):US$24.2 Bn
  • Projected Market Value (2031F): US$35.6 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 5.6%

PMS & Menstrual Health Supplements Market - Report Scope:

PMS and menstrual health supplements are designed to alleviate symptoms associated with premenstrual syndrome (PMS) and menstrual discomfort, including bloating, mood swings, and pain. These supplements often contain vitamins, minerals, herbal extracts, and other natural ingredients aimed at improving menstrual health and overall well-being. The market caters to women across various age groups and health conditions, offering a range of products including dietary supplements, herbal remedies, and functional foods. Market growth is driven by increasing awareness of menstrual health, rising demand for natural and organic supplements, and the growing emphasis on women's health and wellness.

Market Growth Drivers:

The global PMS & Menstrual Health Supplements market is propelled by several key factors, including heightened awareness and acceptance of PMS and menstrual health management solutions. The rising prevalence of PMS and menstrual disorders, coupled with increasing consumer preference for natural and organic supplements, drives market expansion. Technological advancements in supplement formulation, including the development of targeted and personalized supplements, further enhance market growth. Additionally, the growing availability of PMS and menstrual health supplements through online platforms and retail channels provides wider consumer access and convenience.

Market Restraints:

Despite promising growth prospects, the PMS & Menstrual Health Supplements market faces challenges related to regulatory hurdles, product efficacy, and safety concerns. Variations in regulatory standards across regions can create barriers for market entry and product approval. Additionally, the lack of standardized clinical evidence supporting the effectiveness of some supplements can impact consumer trust and market growth. High product costs and limited reimbursement options also pose challenges for widespread adoption, particularly in price-sensitive markets.

Market Opportunities:

The PMS & Menstrual Health Supplements market presents significant growth opportunities driven by evolving consumer preferences, demographic trends, and innovation in supplement formulations. The increasing focus on personalized health and wellness solutions creates opportunities for the development of tailored supplements that address specific PMS and menstrual health needs. Expanding distribution channels, including e-commerce platforms and health stores, enhance market reach and accessibility. Strategic partnerships, investment in research and development, and the introduction of innovative supplement formulations are crucial to capitalize on emerging opportunities and sustain market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the PMS & Menstrual Health Supplements market globally?
  • Which supplement types and formulations are gaining traction in the market?
  • How are advancements in supplement technology reshaping the competitive landscape of the PMS & Menstrual Health Supplements market?
  • Who are the key players contributing to the PMS & Menstrual Health Supplements market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global PMS & Menstrual Health Supplements market?

Competitive Intelligence and Business Strategy:

Leading players in the global PMS & Menstrual Health Supplements market, including companies like Herbalife Nutrition Ltd., Amway Corporation, and Nature's Way, focus on product innovation, consumer education, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced supplement formulations, including personalized and targeted solutions for PMS and menstrual health. Collaborations with healthcare professionals, wellness influencers, and retail partners facilitate market access and promote consumer trust. Moreover, emphasis on quality assurance, clinical research, and evidence-based practices fosters market growth and enhances consumer satisfaction in the dynamic PMS & Menstrual Health Supplements landscape.

Key Companies Profiled:

  • Herbalife International of America, Inc.
  • Pharmavite LLC
  • Nature's Bounty
  • Amway; GNC Holdings Inc.
  • USANA Health Sciences, Inc.
  • GlaxoSmithKline Plc
  • MetP Pharma AG
  • RBK Nutraceuticals Pty Ltd.
  • Archer Daniels Midland
  • Power Gummies
  • Looni, DM Pharma

PMS & Menstrual Health Supplements Market Segmentation

By Product

  • Single Nutritional Supplements
  • Combined Nutritional Supplements

By Consumer Group Outlook

  • Premenstrual Syndrome (PMS)
  • Perimenopause

By Formulation

  • Capsules/Tablets
  • Powder
  • Softgels

By Symptom

  • Bloating and Fluid Retention
  • Mood Swings and Irritability
  • Breast Tenderness
  • Cramps and Pain
  • Fatigue
  • Anxiety

By Sales Channel

  • Online sales channel
  • Direct sales channel
  • Pharmacies/Drug stores
  • Other offline channels

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global PMS & Menstrual Health Supplements Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Industry Developments and Key Market Events
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Meat Substitutes Market: Value Chain
    • 2.3.1. List of key players
    • 2.3.2. List of key distributors
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. Covid-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter Five Force's Analysis

3. Key Regulations/ Standards

4. Price Trend Analysis, 2019-2031

  • 4.1. Key Factors Impacting Prices
  • 4.2. Prices by Source

5. Global PMS & Menstrual Health Supplements Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 5.1. Market Size (US$ Bn) Analysis and Forecast
    • 5.1.1. Historical Market Size Analysis, 2019-2023
    • 5.1.2. Current Market Size Forecast, 2023-2031
  • 5.2. Global PMS & Menstrual Health Supplements Market Outlook: Product Type
    • 5.2.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 5.2.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 5.2.2.1. Single Nutritional Supplements
        • 5.2.2.1.1. Vitamins
        • 5.2.2.1.2. Minerals
        • 5.2.2.1.3. Herbal supplements
        • 5.2.2.1.4. Others
      • 5.2.2.2. Combined Nutritional Supplements
    • 5.2.3. Market Attractiveness Analysis: Product Type
  • 5.3. Global PMS & Menstrual Health Supplements Market Outlook: By Consumer Group
    • 5.3.1. Historical Market Size (US$ Bn) Analysis By Consumer Group, 2019-2023
    • 5.3.2. Current Market Size (US$ Bn) Forecast By Consumer Group, 2024-2031
        • 5.3.2.1.1. Premenstrual Syndrome (PMS)
        • 5.3.2.1.2. Perimenopause
    • 5.3.3. Market Attractiveness Analysis: Consumer Group
  • 5.4. Global PMS & Menstrual Health Supplements Market Outlook: Formulation
    • 5.4.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019-2023
    • 5.4.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024-2031
        • 5.4.2.1.1. Capsules/Tablets
        • 5.4.2.1.2. Powder
        • 5.4.2.1.3. Softgels
        • 5.4.2.1.4. Others
    • 5.4.3. Market Attractiveness Analysis: Formulation
  • 5.5. Global PMS & Menstrual Health Supplements Market Outlook: Symptom
    • 5.5.1. Historical Market Size (US$ Bn) Analysis By Symptom, 2019-2023
    • 5.5.2. Current Market Size (US$ Bn) Forecast By Symptom, 2024-2031
      • 5.5.2.1. Bloating and Fluid Retention
      • 5.5.2.2. Mood Swings and Irritability
      • 5.5.2.3. Breast Tenderness
      • 5.5.2.4. Cramps and Pain
      • 5.5.2.5. Fatigue
      • 5.5.2.6. Anxiety
      • 5.5.2.7. Others
    • 5.5.3. Market Attractiveness Analysis: Symptom
  • 5.6. Global PMS & Menstrual Health Supplements Market Outlook: By Sales Channel
    • 5.6.1. Historical Market Size (US$ Bn) Analysis By Category, 2019-2023
    • 5.6.2. Current Market Size (US$ Bn) Forecast By Category, 2024-2031
      • 5.6.2.1. Online sales channel
      • 5.6.2.2. Direct sales channel
      • 5.6.2.3. Pharmacies/Drug stores
      • 5.6.2.4. Other offline channels
    • 5.6.3. Market Attractiveness Analysis: Sales Channel

6. Global PMS & Menstrual Health Supplements Market Outlook: Region

  • 6.1. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 6.2. Current Market Size (US$ Bn) Forecast By Region, 2024-2031
    • 6.2.1. North America
    • 6.2.2. Europe
    • 6.2.3. East Asia
    • 6.2.4. South Asia and Oceania
    • 6.2.5. Latin America
    • 6.2.6. Middle East & Africa
  • 6.3. Market Attractiveness Analysis: Region

7. North America PMS & Menstrual Health Supplements Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 7.1.1. By Country
    • 7.1.2. By Product Type
    • 7.1.3. By Consumer Group
    • 7.1.4. By Formulation
    • 7.1.5. By Symptom
    • 7.1.6. By Sales Channel
  • 7.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. North America PMS & Menstrual Health Supplements Market Outlook: Product Type
    • 7.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 7.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 7.3.2.1. Single Nutritional Supplements
        • 7.3.2.1.1. Vitamins
        • 7.3.2.1.2. Minerals
        • 7.3.2.1.3. Herbal supplements
        • 7.3.2.1.4. Others
      • 7.3.2.2. Combined Nutritional Supplements
    • 7.3.3. Market Attractiveness Analysis: Product Type
  • 7.4. North America PMS & Menstrual Health Supplements Market Outlook: By Consumer Group
    • 7.4.1. Historical Market Size (US$ Bn) Analysis By Consumer Group, 2019-2023
    • 7.4.2. Current Market Size (US$ Bn) Forecast By Consumer Group, 2024-2031
      • 7.4.2.1. Premenstrual Syndrome (PMS)
      • 7.4.2.2. Perimenopause
    • 7.4.3. Market Attractiveness Analysis: Consumer Group
  • 7.5. North America PMS & Menstrual Health Supplements Market Outlook: Formulation
    • 7.5.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019-2023
    • 7.5.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024-2031
      • 7.5.2.1. Capsules/Tablets
      • 7.5.2.2. Powder
      • 7.5.2.3. Softgels
      • 7.5.2.4. Others
    • 7.5.3. Market Attractiveness Analysis: Formulation
  • 7.6. North America PMS & Menstrual Health Supplements Market Outlook: Symptom
    • 7.6.1. Historical Market Size (US$ Bn) Analysis By Symptom, 2019-2023
    • 7.6.2. Current Market Size (US$ Bn) Forecast By Symptom, 2024-2031
      • 7.6.2.1. Bloating and Fluid Retention
      • 7.6.2.2. Mood Swings and Irritability
      • 7.6.2.3. Breast Tenderness
      • 7.6.2.4. Cramps and Pain
      • 7.6.2.5. Fatigue
      • 7.6.2.6. Anxiety
      • 7.6.2.7. Others
    • 7.6.3. Market Attractiveness Analysis: Symptom
  • 7.7. North America PMS & Menstrual Health Supplements Market Outlook: By Sales Channel
    • 7.7.1. Historical Market Size (US$ Bn) Analysis By Category, 2019-2023
    • 7.7.2. Current Market Size (US$ Bn) Forecast By Category, 2024-2031
      • 7.7.2.1. Online sales channel
      • 7.7.2.2. Direct sales channel
      • 7.7.2.3. Pharmacies/Drug stores
      • 7.7.2.4. Other offline channels
    • 7.7.3. Market Attractiveness Analysis: Sales Channel
  • 7.8. Market Attractiveness Analysis

8. Europe PMS & Menstrual Health Supplements Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 8.1.1. By Country
    • 8.1.2. By Product Type
    • 8.1.3. By Consumer Group
    • 8.1.4. By Formulation
    • 8.1.5. By Symptom
    • 8.1.6. By Sales Channel
  • 8.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 8.2.1. Germany
    • 8.2.2. France
    • 8.2.3. U.K.
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Russia
  • 8.3. Europe PMS & Menstrual Health Supplements Market Outlook: Product Type
    • 8.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 8.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 8.3.2.1. Single Nutritional Supplements
        • 8.3.2.1.1. Vitamins
        • 8.3.2.1.2. Minerals
        • 8.3.2.1.3. Herbal supplements
        • 8.3.2.1.4. Others
      • 8.3.2.2. Combined Nutritional Supplements
    • 8.3.3. Market Attractiveness Analysis: Product Type
  • 8.4. Europe PMS & Menstrual Health Supplements Market Outlook: By Consumer Group
    • 8.4.1. Historical Market Size (US$ Bn) Analysis By Consumer Group, 2019-2023
    • 8.4.2. Current Market Size (US$ Bn) Forecast By Consumer Group, 2024-2031
      • 8.4.2.1. Premenstrual Syndrome (PMS)
      • 8.4.2.2. Perimenopause
    • 8.4.3. Market Attractiveness Analysis: Consumer Group
  • 8.5. Europe PMS & Menstrual Health Supplements Market Outlook: Formulation
    • 8.5.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019-2023
    • 8.5.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024-2031
      • 8.5.2.1. Capsules/Tablets
      • 8.5.2.2. Powder
      • 8.5.2.3. Softgels
      • 8.5.2.4. Others
    • 8.5.3. Market Attractiveness Analysis: Formulation
  • 8.6. Europe PMS & Menstrual Health Supplements Market Outlook: Symptom
    • 8.6.1. Historical Market Size (US$ Bn) Analysis By Symptom, 2019-2023
    • 8.6.2. Current Market Size (US$ Bn) Forecast By Symptom, 2024-2031
      • 8.6.2.1. Bloating and Fluid Retention
      • 8.6.2.2. Mood Swings and Irritability
      • 8.6.2.3. Breast Tenderness
      • 8.6.2.4. Cramps and Pain
      • 8.6.2.5. Fatigue
      • 8.6.2.6. Anxiety
      • 8.6.2.7. Others
    • 8.6.3. Market Attractiveness Analysis: Symptom
  • 8.7. Europe PMS & Menstrual Health Supplements Market Outlook: By Sales Channel
    • 8.7.1. Historical Market Size (US$ Bn) Analysis By Category, 2019-2023
    • 8.7.2. Current Market Size (US$ Bn) Forecast By Category, 2024-2031
      • 8.7.2.1. Online sales channel
      • 8.7.2.2. Direct sales channel
      • 8.7.2.3. Pharmacies/Drug stores
      • 8.7.2.4. Other offline channels
    • 8.7.3. Market Attractiveness Analysis: Sales Channel
  • 8.8. Market Attractiveness Analysis

9. East Asia PMS & Menstrual Health Supplements Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 9.1.1. By Country
    • 9.1.2. By Product Type
    • 9.1.3. By Consumer Group
    • 9.1.4. By Formulation
    • 9.1.5. By Symptom
    • 9.1.6. By Sales Channel
  • 9.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 9.2.1. China
    • 9.2.2. Japan
    • 9.2.3. South Korea
  • 9.3. East Asia PMS & Menstrual Health Supplements Market Outlook: Product Type
    • 9.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 9.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 9.3.2.1. Single Nutritional Supplements
        • 9.3.2.1.1. Vitamins
        • 9.3.2.1.2. Minerals
        • 9.3.2.1.3. Herbal supplements
        • 9.3.2.1.4. Others
      • 9.3.2.2. Combined Nutritional Supplements
    • 9.3.3. Market Attractiveness Analysis: Product Type
  • 9.4. East Asia PMS & Menstrual Health Supplements Market Outlook: By Consumer Group
    • 9.4.1. Historical Market Size (US$ Bn) Analysis By Consumer Group, 2019-2023
    • 9.4.2. Current Market Size (US$ Bn) Forecast By Consumer Group, 2024-2031
      • 9.4.2.1. Premenstrual Syndrome (PMS)
      • 9.4.2.2. Perimenopause
    • 9.4.3. Market Attractiveness Analysis: Consumer Group
  • 9.5. East Asia PMS & Menstrual Health Supplements Market Outlook: Formulation
    • 9.5.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019-2023
    • 9.5.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024-2031
      • 9.5.2.1. Capsules/Tablets
      • 9.5.2.2. Powder
      • 9.5.2.3. Softgels
      • 9.5.2.4. Others
    • 9.5.3. Market Attractiveness Analysis: Formulation
  • 9.6. East Asia PMS & Menstrual Health Supplements Market Outlook: Symptom
    • 9.6.1. Historical Market Size (US$ Bn) Analysis By Symptom, 2019-2023
    • 9.6.2. Current Market Size (US$ Bn) Forecast By Symptom, 2024-2031
      • 9.6.2.1. Bloating and Fluid Retention
      • 9.6.2.2. Mood Swings and Irritability
      • 9.6.2.3. Breast Tenderness
      • 9.6.2.4. Cramps and Pain
      • 9.6.2.5. Fatigue
      • 9.6.2.6. Anxiety
      • 9.6.2.7. Others
    • 9.6.3. Market Attractiveness Analysis: Symptom
  • 9.7. East Asia PMS & Menstrual Health Supplements Market Outlook: By Sales Channel
    • 9.7.1. Historical Market Size (US$ Bn) Analysis By Category, 2019-2023
    • 9.7.2. Current Market Size (US$ Bn) Forecast By Category, 2024-2031
      • 9.7.2.1. Online sales channel
      • 9.7.2.2. Direct sales channel
      • 9.7.2.3. Pharmacies/Drug stores
      • 9.7.2.4. Other offline channels
    • 9.7.3. Market Attractiveness Analysis: Sales Channel

10. South Asia & Oceania PMS & Menstrual Health Supplements Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 10.1.1. By Country
    • 10.1.2. By Product Type
    • 10.1.3. By Consumer Group
    • 10.1.4. By Formulation
    • 10.1.5. By Symptom
    • 10.1.6. By Sales Channel
  • 10.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 10.2.1. India
    • 10.2.2. Southeast Asia
    • 10.2.3. ANZ
    • 10.2.4. Rest of South Asia & Oceania
  • 10.3. South Asia & Oceania PMS & Menstrual Health Supplements Market Outlook: Product Type
    • 10.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 10.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 10.3.2.1. Single Nutritional Supplements
        • 10.3.2.1.1. Vitamins
        • 10.3.2.1.2. Minerals
        • 10.3.2.1.3. Herbal supplements
        • 10.3.2.1.4. Others
      • 10.3.2.2. Combined Nutritional Supplements
    • 10.3.3. Market Attractiveness Analysis: Product Type
  • 10.4. South Asia & Oceania PMS & Menstrual Health Supplements Market Outlook: By Consumer Group
    • 10.4.1. Historical Market Size (US$ Bn) Analysis By Consumer Group, 2019-2023
    • 10.4.2. Current Market Size (US$ Bn) Forecast By Consumer Group, 2024-2031
      • 10.4.2.1. Premenstrual Syndrome (PMS)
      • 10.4.2.2. Perimenopause
    • 10.4.3. Market Attractiveness Analysis: Consumer Group
  • 10.5. South Asia & Oceania PMS & Menstrual Health Supplements Market Outlook: Formulation
    • 10.5.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019-2023
    • 10.5.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024-2031
      • 10.5.2.1. Capsules/Tablets
      • 10.5.2.2. Powder
      • 10.5.2.3. Softgels
      • 10.5.2.4. Others
    • 10.5.3. Market Attractiveness Analysis: Formulation
  • 10.6. South Asia & Oceania PMS & Menstrual Health Supplements Market Outlook: Symptom
    • 10.6.1. Historical Market Size (US$ Bn) Analysis By Symptom, 2019-2023
    • 10.6.2. Current Market Size (US$ Bn) Forecast By Symptom, 2024-2031
      • 10.6.2.1. Bloating and Fluid Retention
      • 10.6.2.2. Mood Swings and Irritability
      • 10.6.2.3. Breast Tenderness
      • 10.6.2.4. Cramps and Pain
      • 10.6.2.5. Fatigue
      • 10.6.2.6. Anxiety
      • 10.6.2.7. Others
    • 10.6.3. Market Attractiveness Analysis: Symptom
  • 10.7. Europe PMS & Menstrual Health Supplements Market Outlook: By Sales Channel
    • 10.7.1. Historical Market Size (US$ Bn) Analysis By Category, 2019-2023
    • 10.7.2. Current Market Size (US$ Bn) Forecast By Category, 2024-2031
      • 10.7.2.1. Online sales channel
      • 10.7.2.2. Direct sales channel
      • 10.7.2.3. Pharmacies/Drug stores
      • 10.7.2.4. Other offline channels
    • 10.7.3. Market Attractiveness Analysis: Sales Channel
  • 10.8. Market Attractiveness Analysis

11. Latin America PMS & Menstrual Health Supplements Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 11.1.1. By Country
    • 11.1.2. By Product Type
    • 11.1.3. By Consumer Group
    • 11.1.4. By Formulation
    • 11.1.5. By Symptom
    • 11.1.6. By Sales Channel
  • 11.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 11.2.1. Brazil
    • 11.2.2. Mexico
  • 11.3. Latin America PMS & Menstrual Health Supplements Market Outlook: Product Type
    • 11.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 11.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 11.3.2.1. Single Nutritional Supplements
        • 11.3.2.1.1. Vitamins
        • 11.3.2.1.2. Minerals
        • 11.3.2.1.3. Herbal supplements
        • 11.3.2.1.4. Others
      • 11.3.2.2. Combined Nutritional Supplements
    • 11.3.3. Market Attractiveness Analysis: Product Type
  • 11.4. Latin America PMS & Menstrual Health Supplements Market Outlook: By Consumer Group
    • 11.4.1. Historical Market Size (US$ Bn) Analysis By Consumer Group, 2019-2023
    • 11.4.2. Current Market Size (US$ Bn) Forecast By Consumer Group, 2024-2031
      • 11.4.2.1. Premenstrual Syndrome (PMS)
      • 11.4.2.2. Perimenopause
    • 11.4.3. Market Attractiveness Analysis: Consumer Group
  • 11.5. Latin America PMS & Menstrual Health Supplements Market Outlook: Formulation
    • 11.5.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019-2023
    • 11.5.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024-2031
      • 11.5.2.1. Capsules/Tablets
      • 11.5.2.2. Powder
      • 11.5.2.3. Softgels
      • 11.5.2.4. Others
    • 11.5.3. Market Attractiveness Analysis: Formulation
  • 11.6. Latin America PMS & Menstrual Health Supplements Market Outlook: Symptom
    • 11.6.1. Historical Market Size (US$ Bn) Analysis By Symptom, 2019-2023
    • 11.6.2. Current Market Size (US$ Bn) Forecast By Symptom, 2024-2031
      • 11.6.2.1. Bloating and Fluid Retention
      • 11.6.2.2. Mood Swings and Irritability
      • 11.6.2.3. Breast Tenderness
      • 11.6.2.4. Cramps and Pain
      • 11.6.2.5. Fatigue
      • 11.6.2.6. Anxiety
      • 11.6.2.7. Others
    • 11.6.3. Market Attractiveness Analysis: Symptom
  • 11.7. Latin America PMS & Menstrual Health Supplements Market Outlook: By Sales Channel
    • 11.7.1. Historical Market Size (US$ Bn) Analysis By Category, 2019-2023
    • 11.7.2. Current Market Size (US$ Bn) Forecast By Category, 2024-2031
      • 11.7.2.1. Online sales channel
      • 11.7.2.2. Direct sales channel
      • 11.7.2.3. Pharmacies/Drug stores
      • 11.7.2.4. Other offline channels
    • 11.7.3. Market Attractiveness Analysis: Sales Channel
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa PMS & Menstrual Health Supplements Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 12.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 12.1.1. By Country
    • 12.1.2. By Product Type
    • 12.1.3. By Consumer Group
    • 12.1.4. By Formulation
    • 12.1.5. By Symptom
    • 12.1.6. By Sales Channel
  • 12.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 12.2.1. GCC
    • 12.2.2. South Africa
    • 12.2.3. Northern Africa
  • 12.3. Middle East & Africa PMS & Menstrual Health Supplements Market Outlook: Product Type
    • 12.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 12.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 12.3.2.1. Single Nutritional Supplements
        • 12.3.2.1.1. Vitamins
        • 12.3.2.1.2. Minerals
        • 12.3.2.1.3. Herbal supplements
        • 12.3.2.1.4. Others
      • 12.3.2.2. Combined Nutritional Supplements
    • 12.3.3. Market Attractiveness Analysis: Product Type
  • 12.4. Middle East & Africa PMS & Menstrual Health Supplements Market Outlook: By Consumer Group
    • 12.4.1. Historical Market Size (US$ Bn) Analysis By Consumer Group, 2019-2023
    • 12.4.2. Current Market Size (US$ Bn) Forecast By Consumer Group, 2024-2031
      • 12.4.2.1. Premenstrual Syndrome (PMS)
      • 12.4.2.2. Perimenopause
    • 12.4.3. Market Attractiveness Analysis: Consumer Group
  • 12.5. Middle East & Africa PMS & Menstrual Health Supplements Market Outlook: Formulation
    • 12.5.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019-2023
    • 12.5.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024-2031
      • 12.5.2.1. Capsules/Tablets
      • 12.5.2.2. Powder
      • 12.5.2.3. Softgels
      • 12.5.2.4. Others
    • 12.5.3. Market Attractiveness Analysis: Formulation
  • 12.6. Middle East & Africa PMS & Menstrual Health Supplements Market Outlook: Symptom
    • 12.6.1. Historical Market Size (US$ Bn) Analysis By Symptom, 2019-2023
    • 12.6.2. Current Market Size (US$ Bn) Forecast By Symptom, 2024-2031
      • 12.6.2.1. Bloating and Fluid Retention
      • 12.6.2.2. Mood Swings and Irritability
      • 12.6.2.3. Breast Tenderness
      • 12.6.2.4. Cramps and Pain
      • 12.6.2.5. Fatigue
      • 12.6.2.6. Anxiety
      • 12.6.2.7. Others
    • 12.6.3. Market Attractiveness Analysis: Symptom
  • 12.7. Middle East & Africa PMS & Menstrual Health Supplements Market Outlook: By Sales Channel
    • 12.7.1. Historical Market Size (US$ Bn) Analysis By Category, 2019-2023
    • 12.7.2. Current Market Size (US$ Bn) Forecast By Category, 2024-2031
      • 12.7.2.1. Online sales channel
      • 12.7.2.2. Direct sales channel
      • 12.7.2.3. Pharmacies/Drug stores
      • 12.7.2.4. Other offline channels
    • 12.7.3. Market Attractiveness Analysis: Sales Channel
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
    • 13.2.3. Tier Structure Analysis
    • 13.2.4. Regional Presence Analysis
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Herbalife International of America, Inc.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Pharmavite LLC
    • 13.3.3. Nature's Bounty
    • 13.3.4. Amway
    • 13.3.5. GNC Holdings Inc.
    • 13.3.6. USANA Health Sciences, Inc.
    • 13.3.7. MetP Pharma AG
    • 13.3.8. RBk Neutraceuticals Pty. Ltd.
    • 13.3.9. Archer Daniels Midland
    • 13.3.10. Power Gummies
    • 13.3.11. Looni
    • 13.3.12. DM Pharma

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations